| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +110,000 | 9.5% | $24.07 | +$2,648,200 |
| Sells | 9 | -1,048,021 | 91% | $22.84 | -$23,940,038 |
| Net | -7 | -938,021 | -81% | -$21,291,838 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| PATRICK J. MCENANY | Director, Chairman of Board of Directors | $105,777,977 | -$5,217,338 | -4.7% | 29 Dec 2025 |
| Steve Miller | Chief Op. & Scientific Officer | $29,217,712 | -$2,332,200 | -7.4% | 29 Dec 2025 |
| DONALD A. DENKHAUS | Director | $12,120,589 | 29 Dec 2025 | ||
| Richard J. Daly | President and CEO, Director | $11,337,222 | +$1,266,559 | +13% | 05 Jan 2026 |
| David S. Tierney | Director | $9,508,911 | -$525,200 | -5.2% | 29 Dec 2025 |
| Brian Elsbernd | Chief Compliance/Legal Officer | $8,121,002 | -$2,135,133 | -21% | 29 Dec 2025 |
| GARY INGENITO | Chief Med. & Reg. Officer | $3,901,700 | -$10,670,330 | -73% | 13 May 2025 |
| Preethi Sundaram | Chief Strategy Officer | $2,812,514 | -$103,649 | -3.6% | 29 Dec 2025 |
| Jeffrey Del | Chief Commercial Officer | $2,423,667 | -$952,627 | -28% | 29 Dec 2025 |
| Michael W. Kalb | Executive Vice President & CFO | $2,226,495 | 05 Jan 2026 | ||
| Charles B. O'Keeffe | Director | $2,107,267 | 14 Feb 2025 | ||
| ALICIA GRANDE | VP, Treasurer and CFO | $1,404,569 | 27 Dec 2023 | ||
| Tamar Thompson | Director | $475,599 | 08 Dec 2025 | ||
| Molly Harper | Director | $372,235 | -$621,920 | -63% | 29 Dec 2025 |
| PHILIP H. COELHO | Director | $231,522 | 04 May 2023 | ||
| Daniel J. Curran | Director | $0 | 20 Nov 2025 | ||
| William T. Andrews | Chief Medical Officer | $0 | 20 Nov 2025 | ||
| Gregg Russo | Chief HR Officer | $0 | 20 Nov 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|